Skip to main content
. 2023 Jan 12;14:1–13. doi: 10.18632/oncotarget.28341

Figure 2. STRO-001 showed potent cell killing activity on NHL cell lines.

Figure 2

(A) STRO-001 cell killing curves on 4 ABC-like DLBCL cell lines; (B) STRO-001 cell killing curves on 9 GCB-like DLBCL cell lines; (C) STRO-001 cell killing curves on 4 MCL cell lines.